Results 31 to 40 of about 905 (194)

Mast cell-related disorders presenting with Kounis syndrome [PDF]

open access: yes, 2016
Letter to the Editor.-- et al.Peer ...
Escribano, Luis   +9 more
core   +1 more source

Mast cell activation syndrome. About a clinical case

open access: yesRevista Alergia México, 2019
Background: Monoclonal mast cell activation syndrome is included in mast cell activation disorders in which, after a diagnostic process, it is not possible to meet the required criteria for a diagnosis of systemic mastocytosis.
Ricardo Cardona   +4 more
doaj   +1 more source

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal [PDF]

open access: yes, 2011
Activation of tissue mast cells (MCs) and their abnormal growth and accumulation in various organs are typically found in primary MC disorders also referred to as mastocytosis.
Akin C   +73 more
core   +1 more source

Mastocitoma solitario. Comunicación de un caso

open access: yesRevista Alergia México, 2023
Antecedentes: El mastocitoma solitario es una variante de mastocitosis cutánea de buen pronóstico, congénita, que aparece durante las primeras semanas de vida.
Camila Delgadillo Jordán
doaj   +1 more source

Mastocitosis sistémica: Revisión sistemática [PDF]

open access: yesAnales de Medicina Interna, 2008
La mastocitosis es una enfermedad definida por un crecimiento anormal y por la acumulación de mastocitos. En la clasificación de consenso de la OMS del 2001, se distinguió entre procesos bien limitados a piel (mastocitosis cutánea) o bien acumulados a nivel de otros tejidos: médula ósea y/u otros órganos extracutáneos (mastocitosis sistémica) como ...
Molina-Garrido, M.J.   +6 more
openaire   +3 more sources

PB1958 SUDDEN ONSET HEARING AND VISUAL LOSS: AN UNUSUAL PRESENTATION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

open access: yesHemaSphere, Volume 3, Issue S1, Page 889-890, June 2019., 2019
Background: Hearing loss and blindness are seldom encountered as primary manifestations in patients with chronic myeloid leukemia. Chronic myeloid leukemia (CML) commonly presents with weakness, dysphagia, abdominal distension and pain and rarely constitutional symptoms.
S., S. Tandon, R. Gupta, S. Nityanand
wiley   +1 more source

How patients remember when they were given the diagnosis. About fifteen testimonies related to rare diseases [PDF]

open access: yes, 2014
Doctor-patient communication has led, in recent years, great interest among the health community. Communicating the diagnosis is one of the key moments for people suffering an illness.
Arcos Urrutia, Juan Manuel   +2 more
core   +2 more sources

Mastocitosis Cutánea y Urticaria Pigmentosa: Estudio de Casos y Actualización Terapéutica [PDF]

open access: yes, 2023
Cutaneous mastocytosis is a rare disease with a good prognosis. It is characterized by the invasion of mast cells, in abnormal amount, in the skin.
Burgos Iturra , Guillermo
core   +2 more sources

PB1959 THE ROLE OF FLOW CYTOMETRY IN DIFFERENTIAL DIAGNOSIS OF CMML AND REACTIVE MONOCYTOSIS. THE LIPID SIGNAL PATHWAY CHARACTERISTICS IN CLONAL MONOCYTOSIS

open access: yesHemaSphere, Volume 3, Issue S1, Page 890, June 2019., 2019
Background: Myelodysplastic syndrome (MDS) is a heterogeneous group of diseases characterized by ineffective erythropoiesis and dysplasia. MDS and its subtype CMML is highly associated with chronic inflammatory and autoimmune diseases; however the combination of MDS with other bone marrow neoplasms is not a common entity. Only few cases of MDS combined
A. Sevoyan, A. Sevoyan
wiley   +1 more source

Ex vivo identification and characterization of a population of CD13high CD105+ CD45− mesenchymal stem cells in human bone marrow [PDF]

open access: yes, 2016
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.[Introduction]: Mesenchymal stem cells (MSCs) are multipotent cells capable of self-renewal and multilineage differentiation.
Amaral, Ana Teresa   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy